The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 07, 2015

Filed:

Oct. 24, 2012
Applicants:

Chung-ming Hsieh, Newton, MA (US);

Alexander Ivanov, Lexington, MA (US);

Wendy Waegell, Brookfield, MA (US);

Yuliya Kutskova, Northborough, MA (US);

John Memmott, Framingham, MA (US);

Lorenzo Benatuil, Northborough, MA (US);

Jacqueline Bixby, Auburn, MA (US);

Emma Fung, Northborough, MA (US);

Sahana Bose, Marlborough, MA (US);

Alyssa Brito, Hudson, MA (US);

Inventors:

Chung-Ming Hsieh, Newton, MA (US);

Alexander Ivanov, Lexington, MA (US);

Wendy Waegell, Brookfield, MA (US);

Yuliya Kutskova, Northborough, MA (US);

John Memmott, Framingham, MA (US);

Lorenzo Benatuil, Northborough, MA (US);

Jacqueline Bixby, Auburn, MA (US);

Emma Fung, Northborough, MA (US);

Sahana Bose, Marlborough, MA (US);

Alyssa Brito, Hudson, MA (US);

Assignee:

AbbVie Inc., North Chicago, IL (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/395 (2006.01); C07K 16/00 (2006.01); C07K 16/18 (2006.01); C07K 16/22 (2006.01); C07K 16/24 (2006.01); A61K 31/353 (2006.01); A61K 31/439 (2006.01); A61K 31/44 (2006.01); A61K 31/4439 (2006.01); A61K 31/519 (2006.01); A61K 31/56 (2006.01); A61K 38/13 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61K 38/21 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); C07K 16/22 (2013.01); C07K 16/241 (2013.01); A61K 31/353 (2013.01); A61K 31/439 (2013.01); A61K 31/44 (2013.01); A61K 31/4439 (2013.01); A61K 31/519 (2013.01); A61K 31/56 (2013.01); A61K 38/13 (2013.01); A61K 38/1793 (2013.01); A61K 38/18 (2013.01); A61K 38/1808 (2013.01); A61K 38/1816 (2013.01); A61K 38/19 (2013.01); A61K 38/191 (2013.01); A61K 38/2026 (2013.01); A61K 38/2066 (2013.01); A61K 38/2073 (2013.01); A61K 38/217 (2013.01); A61K 39/3955 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/31 (2013.01); C07K 2317/565 (2013.01); C07K 2317/64 (2013.01); C07K 2317/76 (2013.01); C07K 2317/90 (2013.01); C07K 2317/92 (2013.01);
Abstract

Proteins that bind sclerostin or sclerostin and TNF are described along with there use in composition and methods for treating, preventing, and diagnosing sclerostin related diseases and for detecting sclerostin or sclerostin and TNF in cells, tissues, samples, and compositions.


Find Patent Forward Citations

Loading…